Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benno Weigmann

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
Journal of Crohn'S & Colitis|July 6, 2022
PU.1-driven Th9 Cells Promote Colorectal Cancer in Experimental Colitis Models Through Il-6 Effects in Intestinal Epithelial CellsKatharina Gerlach, Vanessa Popp, Stefan Wirtz, et al.
Nature Immunology|June 9, 2014
TH9 cells that express the transcription factor PU.1 drive T cell-mediated colitis via IL-9 receptor signaling in intestinal epithelial cellsKatharina Gerlach, YouYi Hwang, Alexej Nikolaev, et al.
Gastroenterology|July 5, 2021
Targeting of the Tec Kinase ITK Drives Resolution of T Cell-Mediated Colitis and Emerges as Potential Therapeutic Option in Ulcerative ColitisKristina Lechner, Stefanie Mott, Ragheed Al-Saifi, et al.
Inflammatory Bowel Diseases|May 12, 2026
Targeting the transcription factor GATA3 by the DNAzyme formulation SB012 in patients with moderately-to-severely active ulcerative colitis: a multicenter, randomized, placebo-controlled, phase 2a induction trialRaja Atreya, Tanja Kühbacher, Michael Vieth, et al.
Gastroenterology|March 27, 2017
Activation of Epithelial Signal Transducer and Activator of Transcription 1 by Interleukin 28 Controls Mucosal Healing in Mice With Colitis and Is Increased in Mucosa of Patients With Inflammatory Bowel DiseaseMircea T Chiriac, Barbara Buchen, Alexandra Wandersee, et al.
Gastroenterology|June 17, 2026
TIM3 signaling in effector T cells acts as an immunometabolic switch in the purine degradation pathway to suppress intestinal inflammationAnnkathrin Knauss, Michael Gabel, Cora Kaufmann, et al.
Nature Communications|April 29, 2017
Elevated levels of Bcl-3 inhibits Treg development and function resulting in spontaneous colitisSonja Reißig, Yilang Tang, Alexei Nikolaev, et al.
Gastroenterology|October 14, 2018
Alternative Splice Forms of CYLD Mediate Ubiquitination of SMAD7 to Prevent TGFB Signaling and Promote ColitisYilang Tang, Sonja Reissig, Elke Glasmacher, et al.
Inflammatory Bowel Diseases|June 14, 2022
Label-Free Characterization and Quantification of Mucosal Inflammation in Common Murine Colitis Models With Multiphoton ImagingLucas Kreiss, Oana-Maria Thoma, Sarah Lemire, et al.
The Journal of Clinical Investigation|June 7, 2008
The transcription factor IFN regulatory factor-4 controls experimental colitis in mice via T cell-derived IL-6Jonas Mudter, Lioubov Amoussina, Mirjam Schenk, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Journal of Crohn'S & Colitis|July 6, 2022
PU.1-driven Th9 Cells Promote Colorectal Cancer in Experimental Colitis Models Through Il-6 Effects in Intestinal Epithelial CellsKatharina Gerlach, Vanessa Popp, Stefan Wirtz, et al.
Nature Immunology|June 9, 2014
TH9 cells that express the transcription factor PU.1 drive T cell-mediated colitis via IL-9 receptor signaling in intestinal epithelial cellsKatharina Gerlach, YouYi Hwang, Alexej Nikolaev, et al.
Gastroenterology|July 5, 2021
Targeting of the Tec Kinase ITK Drives Resolution of T Cell-Mediated Colitis and Emerges as Potential Therapeutic Option in Ulcerative ColitisKristina Lechner, Stefanie Mott, Ragheed Al-Saifi, et al.
Inflammatory Bowel Diseases|May 12, 2026
Targeting the transcription factor GATA3 by the DNAzyme formulation SB012 in patients with moderately-to-severely active ulcerative colitis: a multicenter, randomized, placebo-controlled, phase 2a induction trialRaja Atreya, Tanja Kühbacher, Michael Vieth, et al.
Gastroenterology|March 27, 2017
Activation of Epithelial Signal Transducer and Activator of Transcription 1 by Interleukin 28 Controls Mucosal Healing in Mice With Colitis and Is Increased in Mucosa of Patients With Inflammatory Bowel DiseaseMircea T Chiriac, Barbara Buchen, Alexandra Wandersee, et al.
Gastroenterology|June 17, 2026
TIM3 signaling in effector T cells acts as an immunometabolic switch in the purine degradation pathway to suppress intestinal inflammationAnnkathrin Knauss, Michael Gabel, Cora Kaufmann, et al.
Nature Communications|April 29, 2017
Elevated levels of Bcl-3 inhibits Treg development and function resulting in spontaneous colitisSonja Reißig, Yilang Tang, Alexei Nikolaev, et al.
Gastroenterology|October 14, 2018
Alternative Splice Forms of CYLD Mediate Ubiquitination of SMAD7 to Prevent TGFB Signaling and Promote ColitisYilang Tang, Sonja Reissig, Elke Glasmacher, et al.
Inflammatory Bowel Diseases|June 14, 2022
Label-Free Characterization and Quantification of Mucosal Inflammation in Common Murine Colitis Models With Multiphoton ImagingLucas Kreiss, Oana-Maria Thoma, Sarah Lemire, et al.
The Journal of Clinical Investigation|June 7, 2008
The transcription factor IFN regulatory factor-4 controls experimental colitis in mice via T cell-derived IL-6Jonas Mudter, Lioubov Amoussina, Mirjam Schenk, et al.
Pageof 9